Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Nov 19, 2013Boston Scientific Receives FDA Clearance And CE Mark Approval For Direxion™ Torqueable Microcatheter
Proprietary shaft design enables better control in hard-to-navigate vessels
-
Nov 19, 2013
First system to selectively stimulate targeted areas of the brain to manage symptoms of debilitating disease
-
Nov 15, 2013
Patients In Germany receive new transcatheter aortic valve implantation devices specially designed for total control and accurate deployment.
-
Nov 6, 2013
Boston Scientific will participate in the healthcare conference on November 12 in Scottsdale, AZ. Learn how to watch the webcast or replay.
-
Nov 1, 2013
Advances Boston Scientific's ability to more comprehensively serve the rapidly expanding global EP market.
-
Oct 31, 2013
New data demonstrate successful deployment in all 120 patients with no severe paravalvular regurgitation at 30 days
-
Oct 31, 2013
Boston Scientific will participate in the healthcare conference on November 12. Learn how to watch the webcast or replay.
-
Oct 28, 2013
REDUCE-HTN data presented today at TCT demonstrate excellent safety profile.
-
Oct 28, 2013
Boston Scientific Corporation (NYSE: BSX) will highlight the strength of its advanced portfolio and plans for delivering additional meaningful...
-
Oct 28, 2013
Transcatheter Aortic Valve Replacement (TAVR) device offers precise positioning and placement, offering physicians unprecedented control.